XML 32 R22.htm IDEA: XBRL DOCUMENT
v3.22.2.2

OTHER | 9 Months Ended
--- | ---
Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract] |
OTHER | OTHER Cash dividends Dividends declared in the nine months ended September 30, 2022 were as follows:
Dividend per share |  | Date declared |  | Date of record |  | Payment date
$0.0425 |  | 3/8/2022 |  | 5/2/2022 |  | 5/16/2022
$0.0425 |  | 6/23/2022 |  | 8/1/2022 |  | 8/15/2022
$0.0425 |  | 8/2/2022 |  | 11/1/2022 |  | 11/15/2022
During the nine months ended September 30, 2022, the Company paid dividends of $2.9 million. This included payments made on February 14, 2022, May 16, 2022 and August 15, 2022 of $0.9 million, $0.9 million and $0.9 million to stockholders of record on January 31, 2022, May 2, 2022 and August 1, 2022, respectively, and payments of $0.1 million for dividends payable upon the vesting of restricted shares and performance shares. In the three months ended September 30, 2022, the Company reduced retained earnings for the accrual of $1.0 million relating to the dividend payable on November 15, 2022. For the nine months ended September 30, 2022, the Company reduced retained earnings for the accrual of $2.9 million relating to the dividend payable on May 16, 2022, August 15, 2022 and November 15, 2022. On November 1, 2022, the Board of Directors declared a quarterly dividend of 0.0425 per share of common stock payable on February 15, 2023 to stockholders of record on February 1, 2023. Stock repurchase program On March 14, 2022, the Company announced that its Board of Directors of the Company authorized the repurchase of up to $20.0 million of the Company’s common stock, replacing the Company’s previously-authorized $10 million share repurchase program. The repurchase authorization permits the Company to effect the repurchases from time to time through open market purchases and privately negotiated transactions. During the nine months ended September 30, 2022, the Company repurchased 389,743 shares for a total cost of $4.7 million and thereafter retired the shares. Please see Part II, Item 2—Unregistered Sales of Equity Securities and Use of Proceeds included in this Quarterly Report on Form 10-Q. Supplemental cash flow information
| Nine Months Ended September 30,
| 2022 |  | 2021
| (in thousands)
Supplemental disclosure of cash flow information: |  |  |
Cash paid for interest | $ | 10,804 |  |  | $ | 10,279 |
Cash paid for taxes, net of refunds | 6,527 |  |  | 12,616 |
Non-cash investing activities: |  |  |
Net (loss) on dilution and partial sale of Vasconia ownership | $ | — |  |  | $ | (1,673) |
Components of accumulated other comprehensive loss, net
| Three Months Ended September 30, |  | Nine Months Ended September 30,
| 2022 |  | 2021 |  | 2022 |  | 2021
| (in thousands)
Accumulated translation adjustment: |  |  |  |  |  |  |
Balance at beginning of period | $ | (36,175) |  |  | $ | (31,623) |  |  | $ | (31,752) |  |  | $ | (35,846) |
Translation adjustment during period | (2,686) |  |  | (1,122) |  |  | (7,109) |  |  | 1,059 |
Amounts reclassified from accumulated other comprehensive loss (1) | — |  |  | 1,362 |  |  | — |  |  | 3,404 |
Translation Adjustment | (2,686) |  |  | 240 |  |  | (7,109) |  |  | 4,463 |
Balance at end of period | $ | (38,861) |  |  | $ | (31,383) |  |  | $ | (38,861) |  |  | $ | (31,383) |
Accumulated deferred gains (losses) on cash flow hedges: |  |  |  |  |  |  |
Balance at beginning of period | $ | 1,636 |  |  | $ | (1,062) |  |  | $ | 78 |  |  | $ | (1,125) |
Change in unrealized gains (losses) | 624 |  |  | 528 |  |  | 2,201 |  |  | (255) |
Amounts reclassified from accumulated other comprehensive loss: |  |  |  |  |  |  |
Settlement of cash flow hedge (2) | (270) |  |  | 464 |  |  | (289) |  |  | 1,310 |
Net change in cash flow hedges, net of taxes of $92, $(247), $505, $(301) | 354 |  |  | 992 |  |  | 1,912 |  |  | 1,055 |
Balance at end of period | $ | 1,990 |  |  | $ | (70) |  |  | $ | 1,990 |  |  | $ | (70) |
Accumulated effect of retirement benefit obligations: |  |  |  |  |  |  |
Balance at beginning of period | $ | (1,817) |  |  | $ | (2,133) |  |  | $ | (1,875) |  |  | $ | (2,201) |
Amounts reclassified from accumulated other comprehensive loss: (3) |  |  |  |  |  |  |
Amortization of actuarial loss, net of taxes | 29 |  |  | 33 |  |  | 87 |  |  | 101 |
Balance at end of period | $ | (1,788) |  |  | $ | (2,100) |  |  | $ | (1,788) |  |  | $ | (2,100) |
Total accumulated other comprehensive loss at end of period | $ | (38,659) |  |  | $ | (33,553) |  |  | $ | (38,659) |  |  | $ | (33,553) |
(1)Amounts are recorded in equity in (losses) earnings on the unaudited condensed statements of operations. (2)Amounts reclassified are recorded in interest expense and cost of sales on the unaudited condensed consolidated statement of operations. (3)Amounts are recorded in selling, general and administrative expense on the unaudited condensed consolidated statements of operations.

X
- Definition The entire disclosures of supplemental information, including descriptions and amounts, related to the balance sheet, income statement, and/or cash flow statement. + References No definition available. + Details
Name: | us-gaap_AdditionalFinancialInformationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration